SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is currently capturing significant investor interest following a strategic partnership with Palantir to integrate its Athena AI marketing platform into Palantir Foundry, a move seen by the community as a major validator of its enterprise AI capabilities. Investors are actively debating the company's growth trajectory and long-term potential, with discussions focusing on the synergy between these platforms and expectations for continued expansion into enterprise data infrastructure.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently the subject of intense volatility and debate as retail investors and institutions clash over its lofty valuation following a high-profile IPO. Community sentiment is deeply divided between long-term believers citing Starlinks growth potential and skepticism from traders who view the recent price action as a classic over-hyped retail trap.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing heightened market activity following executive orders that highlight quantum sensing as a national priority, with the CEO appearing at the White House alongside major industry leaders. The community is actively debating the company's valuation versus its growth potential, with bulls pointing to the firm's strategic government contracts and upcoming space initiatives, while others express concerns over cash burn and stock performance volatility.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending as investors debate the sustainability of its parabolic rally, which has been fueled by an intense AI-driven memory shortage. While some traders view the stock as a bubble primed for a massive correction, others believe the structural demand for memory infrastructure justifies further upside heading into upcoming sector earnings.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Tech stocks are facing a broad sell-off as a massive market crash in South Korea sparks contagion fears and increases skepticism regarding AI infrastructure spending. While traders are actively debating whether this is a temporary dip to buy or the beginning of a deeper structural unwind, community sentiment remains sharply divided between those calling for a rebound and those bracing for further downside volatility.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently facing significant downward pressure and a breach of key technical support levels, sparking intense debate among community members over whether this represents a long-term accumulation opportunity or a broader structural shift. The conversation is heavily polarized, with many retail investors debating the company's valuation against its ongoing defense and commercial contract wins while short-term traders closely monitor capitulation signals.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnival Corp is seeing significant volatility as investors closely monitor geopolitical tensions in the Middle East and their impact on global oil prices, which directly influence fuel costs for the cruise line. The community is actively debating the stock's potential for a major rally, with many traders looking for a resolution to regional conflicts to unlock value while others remain focused on technical breakouts and earnings guidance.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is experiencing significant volatility driven by a mix of market-wide tech pullbacks and intense investor debate over its speculative valuation versus its long-term potential as a quantum computing leader. Community discourse is currently split between optimism surrounding new government-backed quantum initiatives and skepticism regarding the company's heavy cash burn, potential for dilution, and reliance on acquisitions.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

The Direxion Daily South Korea Bull 3X Shares (KORU) is experiencing extreme volatility driven by regional geopolitical tensions and concentrated exposure to major semiconductor manufacturers like Samsung and SK Hynix. The community is actively debating whether the recent sharp pullbacks represent a high-risk "trap" or a generational buying opportunity, as traders weigh the impact of memory chip supply-demand imbalances against the potential for rapid leveraged decay.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF (TLT) is experiencing heightened volatility as investors weigh the potential for a geopolitical resolution in the Middle East against ongoing concerns about sticky inflation and Federal Reserve policy. The community remains deeply divided, with discussions centered on whether recent data suggests a bottoming for long-term yields or if the bond market remains vulnerable to further inflationary shocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company

A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company PR Newswire SAN FRANCISCO, June 2, 2026 Equity Insider News CommentaryIssued on behalf of GT Biopharma, Inc. (NASDAQ: GTBP)SAN FRANCISCO, June 2...

Outcome of Innate Pharmas 2026 Annual General Meeting

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) announced the voting results of its shareholders at the Annual General Meeting (AGM), which took place on May 21, 2026, in Marseille. All resolutions were voted. A total of 94 votes were cast out of a...

Innate Pharma to participate in the Jefferies Global Healthcare Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced...

Innate Pharma Reports First Quarter 2026 Business Update and Financial Results

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) today reported its business update and consolidated financial results for the quarter ending March 31...

Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026

Regulatory News: Pursuant to the article L. 233-8 II of the French Code de Commerce and the article 223-16 of the French stock-market authorities (Autorit des Marchs Financiers, or AMF) General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) releases its...

Innate Pharma (IPHA) Expected to Announce Quarterly Earnings on Wednesday

Innate Pharma (NASDAQ:IPHA) will be releasing its Q1 2026 TU earnings before the market opens on Wednesday, May 13. (View Earnings Report at...

Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), today announces that the Company will hold a conference call on Wednesday, May 13, 2026 at 1:30 p.m. CEST / 7:30 a.m. EDT, to provide an update on business progress for the first quarter of 2026...

Innate Pharma (NASDAQ:IPHA) Shares Down 0.7% - Here's What Happened

Innate Pharma (NASDAQ:IPHA) Stock Price Down 0.7% - Here's Why...

Innate Pharma to Participate in the D. Boral Capital Global Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in one-on-one investor meetings at the following...

Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), today announced that interim results from the MATISSE Phase 2 study evaluating IPH5201 in combination...

Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Hervé Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié, and François Romagné on September 23, 1999 and is headquartered in Marseille, France.

Innate Pharma - ADR

IPHA Stock Soars Pre-Market After FDA Clears Late-Stage Trial For Lacutamab In Rare Skin Cancers

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.81
Prev Close	$1.81
Open	$1.89
Dividend Yield	0.00%
50-Day Moving Average	$1.67
Beta	0.62
Avg. Volume	155,817.34
PE Ratio	-2.95

52-Week High	$2.63
52-Week Low	$1.17
Market Capitalization	$169.97M
EPS (Annual)	-$0.6195
Price to Book	-6.65
Revenue Per Employee	$19,296.61

Feed

News

Sentiment

Earnings

Fundamentals

Info

IPHAInnate Pharma

Latest IPHA News